NASDAQ:BRKR - Bruker Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $63.80
  • Forecasted Upside: -13.32 %
  • Number of Analysts: 8
  • Breakdown:
  • 1 Sell Ratings
  • 3 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
▲ +0.58 (0.79%)

This chart shows the closing price for BRKR by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Bruker Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for BRKR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BRKR

Analyst Price Target is $63.80
▼ -13.32% Downside Potential
This price target is based on 8 analysts offering 12 month price targets for Bruker in the last 3 months. The average price target is $63.80, with a high forecast of $85.00 and a low forecast of $49.00. The average price target represents a -13.32% upside from the last price of $73.60.

This chart shows the closing price for BRKR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 8 investment analysts is to hold stock in Bruker. This rating has held steady since December 2019, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 6 buy ratings
  • 5 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 5 buy ratings
  • 5 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 5 buy ratings
  • 5 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 1 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/18/2021SVB LeerinkBoost Price TargetOutperform$80.00 ➝ $85.00Medium
6/15/2021Cleveland ResearchUpgradeNeutral ➝ Buy$75.00High
5/6/2021BTIG ResearchBoost Price TargetBuy$73.00 ➝ $80.00Low
5/6/2021SVB LeerinkBoost Price TargetOutperform$70.00 ➝ $80.00Medium
2/17/2021CitigroupBoost Price Target$57.00 ➝ $65.00Low
2/17/2021Stifel NicolausBoost Price TargetIn-Line ➝ Hold$48.00 ➝ $65.00Low
2/5/2021Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight$50.00 ➝ $55.00Medium
1/27/2021SVB LeerinkBoost Price TargetOutperform$50.00 ➝ $70.00High
12/17/2020BTIG ResearchBoost Price TargetBuy$50.00 ➝ $64.00Medium
12/16/2020Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellBoost Price Target$47.00 ➝ $57.00Low
12/16/2020Smith Barney CitigroupBoost Price Target$47.00 ➝ $57.00Low
12/2/2020The Goldman Sachs GroupInitiated CoverageSell$50.00Low
11/16/2020Wolfe ResearchUpgradeUnderperform ➝ Peer PerformMedium
8/4/2020CitigroupBoost Price TargetNeutral$38.00 ➝ $47.00Medium
8/4/2020Wells Fargo & CompanyBoost Price TargetOverweight$42.00 ➝ $52.00High
8/4/2020SVB LeerinkBoost Price TargetOutperform$45.00 ➝ $50.00High
7/20/2020Bank of AmericaBoost Price TargetBuy$43.00 ➝ $49.00Medium
5/13/2020Needham & Company LLCReiterated RatingHoldLow
5/7/2020CitigroupLower Price TargetNeutral$40.00 ➝ $38.00High
5/7/2020Wells Fargo & CompanyLower Price TargetOverweight$50.00 ➝ $42.00High
5/7/2020Needham & Company LLCReiterated RatingHoldHigh
5/1/2020Cleveland ResearchDowngradeBuy ➝ Neutral$37.50Low
4/28/2020UBS GroupLower Price TargetNeutral$53.00 ➝ $41.00Low
4/2/2020Stifel NicolausLower Price TargetHold$52.00 ➝ $35.00High
4/2/2020Wolfe ResearchDowngradeMarket Perform ➝ Underperform$27.00High
3/31/2020Needham & Company LLCDowngradeStrong-Buy ➝ HoldHigh
3/30/2020Wells Fargo & CompanyLower Price Target$60.00 ➝ $50.00Medium
3/30/2020SVB LeerinkLower Price TargetOutperform$58.00 ➝ $46.00High
3/26/2020BarclaysUpgradeEqual Weight ➝ Overweight$52.00 ➝ $48.00High
3/20/2020CitigroupLower Price TargetNeutral$52.00 ➝ $40.00High
2/19/2020Needham & Company LLCBoost Price TargetStrong-Buy$62.00 ➝ $63.00Medium
1/7/2020Wells Fargo & CompanyInitiated CoverageOverweight$60.00Medium
1/6/2020CitigroupInitiated CoverageBuy$52.00Low
1/3/2020Needham & Company LLCInitiated CoverageStrong-Buy$39.00High
12/23/2019Needham & Company LLCReiterated RatingBuy$62.00Low
11/14/2019Stifel NicolausInitiated CoverageHold$53.00High
9/27/2019Needham & Company LLCSet Price TargetBuy$58.00Low
9/26/2019Bank of AmericaUpgradeNeutral ➝ Buy$52.00Low
7/15/2019The Goldman Sachs GroupUpgradeSell ➝ Neutral$32.00 ➝ $48.00Low
6/24/2019Needham & Company LLCSet Price TargetStrong-Buy$46.00 ➝ $57.00Low
6/24/2019BarclaysReiterated RatingHold$44.00Low
6/21/2019Bank of AmericaReiterated RatingNeutral ➝ Neutral$44.00 ➝ $52.00Low
6/21/2019Jefferies Financial GroupBoost Price TargetBuy$45.00 ➝ $56.00Low
6/21/2019BTIG ResearchBoost Price TargetBuy$57.00Low
5/30/2019Wolfe ResearchInitiated CoveragePeer Perform ➝ Peer PerformLow
5/6/2019Needham & Company LLCReiterated RatingStrong-Buy ➝ Strong-Buy$39.00 ➝ $46.00Low
5/3/2019UBS GroupUpgradeSell ➝ Neutral$43.00High
5/3/2019SVB LeerinkUpgradeMarket Perform ➝ Outperform$40.00 ➝ $53.00High
4/12/2019Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy$40.00 ➝ $50.00High
2/12/2019BTIG ResearchReiterated RatingBuy ➝ Buy$42.00 ➝ $44.00High
1/2/2019Needham & Company LLCInitiated CoverageStrong-Buy ➝ Strong-Buy$39.00High
10/9/2018UBS GroupInitiated CoverageSell ➝ Sell$30.00High
9/20/2018Morgan StanleyDowngradeEqual Weight ➝ Underweight$31.00 ➝ $32.00Low
8/3/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$29.00 ➝ $31.00High
7/13/2018Morgan StanleyLower Price TargetEqual Weight$31.00 ➝ $29.00Low
5/6/2018BTIG ResearchSet Price TargetBuy$42.00Low
5/4/2018Bank of AmericaLower Price TargetNeutral ➝ Neutral$37.00 ➝ $34.00N/A
4/11/2018Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$32.00 ➝ $31.00Low
2/9/2018Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$35.00 ➝ $32.00Low
2/9/2018SVB LeerinkBoost Price TargetMarket Perform ➝ Market Perform$32.00 ➝ $34.00High
1/5/2018BTIG ResearchInitiated CoverageBuy ➝ Buy$42.00High
1/3/2018Evercore ISIInitiated CoverageIn-Line$36.00Low
12/21/2017CowenReiterated RatingHold$35.00Low
12/14/2017Morgan StanleyReiterated RatingEqual Weight$35.00Low
11/3/2017CitigroupBoost Price TargetNeutral$29.00 ➝ $34.00N/A
11/3/2017CowenReiterated RatingHold$29.00N/A
11/3/2017Bank of AmericaUpgradeUnderperform ➝ Neutral$34.00N/A
11/3/2017JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral$28.00N/A
9/26/2017The Goldman Sachs GroupReiterated RatingSell ➝ Sell$24.00Low
7/17/2017BarclaysReiterated RatingEqual Weight$26.00 ➝ $30.00Low
7/14/2017CowenReiterated RatingHold$29.00Low
7/12/2017Wells Fargo & CompanyDowngradeMarket Perform ➝ UnderperformMedium
5/15/2017Jefferies Financial GroupReiterated RatingBuy$29.00N/A
5/15/2017Deutsche Bank AktiengesellschaftBoost Price TargetHold$25.00 ➝ $27.00N/A
5/5/2017Deutsche Bank AktiengesellschaftBoost Price TargetHold$25.00 ➝ $27.00Low
5/5/2017Jefferies Financial GroupReiterated RatingBuy$29.00Medium
5/4/2017CowenBoost Price TargetMarket Perform$25.00 ➝ $27.00High
4/27/2017Cleveland ResearchUpgradeNeutral ➝ BuyHigh
3/27/2017Janney Montgomery ScottDowngradeBuy ➝ NeutralLow
2/15/2017BTIG ResearchReiterated RatingHoldN/A
2/14/2017Cantor FitzgeraldSet Price TargetBuy$28.00N/A
2/14/2017BarclaysBoost Price TargetHold$22.00 ➝ $24.00N/A
2/14/2017Jefferies Financial GroupBoost Price TargetBuy$28.00 ➝ $29.00N/A
2/14/2017Evercore ISIBoost Price TargetHold$23.50 ➝ $26.00N/A
1/23/2017Jefferies Financial GroupLower Price TargetBuy$30.00 ➝ $28.00N/A
1/18/2017Deutsche Bank AktiengesellschaftReiterated RatingHold$24.00N/A
1/4/2017BarclaysDowngradeOverweight ➝ Equal Weight$30.00 ➝ $22.00N/A
12/14/2016JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$23.00 ➝ $20.00N/A
12/7/2016Cantor FitzgeraldSet Price TargetBuy$28.00N/A
11/10/2016SVB LeerinkInitiated CoverageMarket Perform$21.00N/A
11/3/2016Cantor FitzgeraldReiterated RatingBuy$28.00N/A
8/4/2016UBS GroupReiterated RatingHold$27.00N/A
8/3/2016BarclaysLower Price TargetOverweight$32.00 ➝ $30.00N/A
8/3/2016Morgan StanleySet Price TargetHold$23.00N/A
8/3/2016Cantor FitzgeraldLower Price TargetBuy$34.00 ➝ $28.00N/A
8/3/2016Janney Montgomery ScottUpgradeNeutral ➝ Buy$28.00N/A
8/3/2016Wells Fargo & CompanyDowngradeOutperform ➝ Market PerformN/A
8/3/2016MizuhoLower Price TargetNeutral$28.00 ➝ $23.00N/A
7/22/2016Cleveland ResearchDowngradeBuy ➝ NeutralN/A
7/22/2016BTIG ResearchReiterated RatingNeutralN/A
(Data available from 6/24/2016 forward)
Bruker logo
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; analytical and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies; and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection. The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, defect-detection equipment for semiconductor process control, and spark optical emission spectroscopy systems, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments. In addition, it offers superconducting and non-superconducting materials and devices. The company serves academic and government research customers; pharmaceutical and biotechnology, diagnostics, chemical, food and beverage, clinical, nanotechnology, semiconductor, and other industrial companies; nonprofit laboratories; academic institutions and medical schools; contract research organizations; nonprofit and for-profit forensics, and environmental and clinical microbiology laboratories; agriculture, food, and beverage safety laboratories; hospitals and government departments; agencies; raw material manufacturers; and other businesses involved in materials analysis through direct sales forces, distributors, independent sales representatives, and other representatives. Bruker Corporation was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
Read More

Today's Range

Now: $73.60
Low: $72.50
High: $74.20

50 Day Range

MA: $69.69
Low: $66.45
High: $75.36

52 Week Range

Now: $73.60
Low: $36.82
High: $75.82


866,375 shs

Average Volume

568,017 shs

Market Capitalization

$11.15 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of Bruker?

The following Wall Street research analysts have issued reports on Bruker in the last twelve months: Bank of America Co., BTIG Research, Citigroup Inc., Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, Cleveland Research, Smith Barney Citigroup, Stifel Nicolaus, SVB Leerink LLC, The Goldman Sachs Group, Inc., TheStreet, Wells Fargo & Company, Wolfe Research, and Zacks Investment Research.
View the latest analyst ratings for BRKR.

What is the current price target for Bruker?

10 Wall Street analysts have set twelve-month price targets for Bruker in the last year. Their average twelve-month price target is $63.80, suggesting a possible downside of 13.3%. SVB Leerink LLC has the highest price target set, predicting BRKR will reach $85.00 in the next twelve months. Bank of America Co. has the lowest price target set, forecasting a price of $49.00 for Bruker in the next year.
View the latest price targets for BRKR.

What is the current consensus analyst rating for Bruker?

Bruker currently has 1 sell rating, 3 hold ratings and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in BRKR, but not buy more shares or sell existing shares.
View the latest ratings for BRKR.

What other companies compete with Bruker?

How do I contact Bruker's investor relations team?

Bruker's physical mailing address is 40 Manning Road, Billerica MA, 01821. The medical research company's listed phone number is (978) 663-3660 and its investor relations email address is [email protected] The official website for Bruker is